Unknown

Dataset Information

0

Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study.


ABSTRACT: To prospectively evaluate diagnostic performance of T2-weighted magnetic resonance (MR) imaging and MR spectroscopic imaging in detecting lesions stratified by pathologic volume and Gleason score in men with clinically determined low-risk prostate cancer.The institutional review board approved this prospective, HIPAA-compliant study. Written informed consent was obtained from 183 men with clinically low-risk prostate cancer (cT1-cT2a, Gleason score≤6 at biopsy, prostate-specific antigen [PSA] level<10 ng/mL [10 μg/L]) undergoing MR imaging before prostatectomy. By using a scale of 1-5 (score 1, definitely no tumor; score 5, definitely tumor), two radiologists independently scored likelihood of tumor per sextant on T2-weighted images. Two spectroscopists jointly recorded locations of lesions with metabolic features consistent with tumor on MR spectroscopic images. Whole-mount step-section histopathologic analysis constituted the reference standard. Diagnostic performance at sextant level (T2-weighted imaging) and detection sensitivities (T2-weighted imaging and MR spectroscopic imaging) for lesions of 0.5 cm3 or larger were calculated.For T2-weighted imaging, areas under the receiver operating characteristic curves for sextant-level detection were 0.77 (reader 1) and 0.82 (reader 2). For lesions of ≥0.5 cm3 and, 1

SUBMITTER: Vargas HA 

PROVIDER: S-EPMC3480819 | biostudies-other | 2012 Nov

REPOSITORIES: biostudies-other

Similar Datasets

2018-12-01 | GSE101908 | GEO
| S-EPMC2663583 | biostudies-literature
| S-EPMC6586429 | biostudies-literature
| S-EPMC7195753 | biostudies-literature
| S-EPMC5584651 | biostudies-literature
| S-EPMC2909433 | biostudies-other
| S-EPMC4298658 | biostudies-literature
| S-EPMC8978254 | biostudies-literature
| S-EPMC6472613 | biostudies-literature
| S-EPMC8724164 | biostudies-literature